Enteric glia (EG) in the enteric nervous system can modulate neuronally regulated gut functions.
| I N T R O D U C T I O N
Local gut reflexes are controlled by the enteric nervous system (ENS), a network of neurons and glia residing in the gut wall. While neuronal innervation and control of the ENS are well established [reviewed in (Furness, Callaghan, Rivera, & Cho, 2014) ], enteric glia (EG) were traditionally recognized as supportive cells due to their inability to generate action potentials (Hanani et al., 2000) . However, cell specific ablation or metabolic poisoning of EG demonstrated their indispensable function in maintenance of gut homeostasis (Bush et al., 1998; Nasser et al., 2006) , and only recent studies have begun to uncover truly active roles of EG in gut motility and physiology.
EG express receptors to all mayor classes of enteric neurotransmitters [reviewed in (Grubisic & Gulbransen, 2017) ], allowing them to respond to neuronal signaling. For instance, neuronal purinergic signaling activates EG in situ via P2Y4 receptor causing a downstream inositol 1,4,5-trisphosphate (IP 3 )-dependent increase in intracellular calcium (Ca 21 ) concentration ([Ca 21 ] i ) (Gulbransen & Sharkey, 2009 ). This Ca 21 increase in EG was also observed during colonic migrating motor complexes (CMMCs) (Broadhead, Bayguinov, Okamoto, Heredia, & Smith, 2012) , indicating that EG get activated during these physiological, neuronally regulated, propulsive contractions of the large intestine.
Furthermore, recent studies showed that inhibition or activation of [Ca 21 ] i dynamics specifically in EG resulted in reduced or enhanced gut motility/contractility (McClain et al., 2014; McClain, Fried, & Gulbransen, 2015) , respectively, demonstrating the active role of EG in gut motility.
Ca
21 excitability of EG suggests that these glial cells may release neuroactive chemical substances known as gliotransmitters. Although gliotransmission is a fairly well studied phenomenon, particularly in astrocytes of the central nervous system (CNS) [(reviewed in (Parpura & Zorec, 2010) ], it has been understudied in the ENS. Nonetheless, adenosine triphosphate (ATP) release through functional unopposed/ unpaired connexons, i.e., hemichannels, was found required for propagation of Ca 21 responses between EG in vitro (Zhang, Segura, Lin, Hu, & Mulholland, 2003) . These hemichannels are composed of connexin 43 (Cx43) and are required for EG propagated Ca 21 responses in situ, consequently modulating gut motility/contraction (McClain et al., 2014) . However, the extent to which Cx43 mutations, like Cx43 G138R , in EG affect gut motility is unknown; Cx43 G138R causes human pathology of oculo-dento-digital dysplasia (ODDD) and hampers gapjunctional coupling yielding an augmented ATP release via unopposed connexons (Dobrowolski, Sommershof, & Willecke, 2007) . Furthermore, it is unknown whether EG may use Ca 21 -dependent exocytosis, the best known pathway for gliotransmitter release from astrocytes of the CNS (Parpura et al., 1994) , otherwise involved in many processes, from memory formation (Pascual et al., 2005) and sleep homeostasis (Halassa et al., 2009 ) to breathing (Gourine et al., 2010) and nociception (Foley, McIver, & Haydon, 2011) . We set to address these issues.
Since EG in situ do not share the same characteristics with the cultured cells [reviewed in (Grubisic & Gulbransen, 2017) ], in the present study, we performed in vivo and ex vivo experiments using various inducible, glial specific, mouse models to: (a) enhance (using a mutated Cx43 form) or reduce availability of Cx43 hemichannel-mediated gliotransmission; and (b) inhibit exocytotic release machinery or the upstream IP 3 -dependent Ca 21 signaling, which is necessary for Ca 21 -/SNARE-dependent exocytosis (Supporting Information Figure S1 ). Our results suggest that increased activity or decreased expression of Cx43 hemichannels in EG correspondingly affects both gut transit in vivo and CMMCs ex vivo.
Inhibition of Ca

21
-dependent exocytosis in EG specifically modifies CMMCs and fecal pellet composition. This study demonstrates differential roles of two distinct mechanisms of gliotransmission, with some apparent cross-talk between them, on the functional output of the gut.
| MATERIALS A ND METHODS
| Animals
Thirteen-to sixteen-week-old hemizygous and wild-type (C57BL/6) mice of both sexes were used. All mice were Helicobacter spp. free and maintained in a temperature (24-258C)-controlled environment on a 12-hour light (7 am on):12-hour dark (7 pm off) cycle, with ad libitum access to food and water. Genotyping was performed by a commercial vendor (Transnetyx, Cordova, TN). All procedures were performed in strict accordance with the National Institutes of Health Guide for the Care and were approved by the Institutional Animal Care and Use
Committee at the University of Alabama at Birmingham.
To investigate specific roles in gut function exhibited by EG Cx43 in gliotransmission, we used two mouse models that utilize inducible Cre-lox system and concurrently report on the Cre activity at the very locus involved in the recombination. The inducible and conditional knockdown Cx43 mice (Cx43-icKD) were generated by crossing a knock-in line with floxed wild-type Cx43 followed by the enhanced cyan fluorescent protein (eCFP) (Cx43 fl::eCFP ) (Degen et al., 2012) and hGFAP::CreER T2 transgenic line (The Jackson Laboratory, Bar Harbor, ME; stock number 012849) (Ganat et al., 2006) that utilizes the Gfa2 fragment of the human glial fibrillary acidic protein (GFAP) promoter (Brenner, Kisseberth, Su, Besnard, & Messing, 1994) (Pascual et al., 2005) . The hGFAP::tTA line utilizes the hGFAP promoter fragment to drive the expression of its tet transactivator (tTA), which in turn activates tet operon (tetO) provided from the other tetO::dnSNARE/tetO::eGFP parental line, Briefly, in the absence of doxocycline (Dox), a tet analog, the dnSNARE mice express the entire cytosolic tail (amino acids 1-96) of synaptobrevin 2 (Sb2 1-96 ), which prevents the formation of ternary SNARE complexes and thus blocks exocytotic gliotransmitter release from GFAP positive cells (Zhang et al., 2004) ; eGFP fluorescence validates the transgene expression.
Another mouse model referred to as VIPP (Marpegan et al., 2011) 
| In vivo assays for fecal pellet output and gut motility
Pellet output and composition, as well as whole gastrointestinal (GI), upper GI and distal colon transit velocities were determined as previously described (Grubisic, Kennedy, Sweatt, & Parpura, 2015) .
| Evaluation of colonic migrating motor complexes using spatiotemporal maps
Tissue preparation, video recordings and spatiotemporal map generation/analysis were previously described elsewhere (Roberts, Murphy, Young, & Bornstein, 2007) . Briefly, the colon was removed, flushed cleaned, cannulated at the both ends (oral and anal) and placed in an organ bath containing physiological saline (20 ml) composed of (in 
| Statistics
The number of mice required for an individual set of experiments was preassessed using power analysis (set at 80% and a 5 0.05). KruskalWallis one-way analysis of variance followed by either Newman-Keuls or Dunn's Multiple Comparisons tests were used to compare groups with equal or different sizes, respectively, using GB-Stat 6. 
| R E S U L T S
3.1 | The extent of availability of Cx43 hemichannels in EG affects gut motility in vivo
Cx43 hemichannels play a role in physiological colonic motility in vivo (McClain et al., 2014) . However, it is unknown whether the gut function can be affected by an increased availability of Cx43 hemichannles, as seen in Cx43 G138R point mutation which hampers gap-junctional coupling and leads to an twofold augmented ATP release via unopposed connexons (Dobrowolski et al., 2008) . To address this issue, we used tamoxifen-inducible Cx43 G138R mice to express this Cx43 point mutation in GFAP positive EG. We also used tamoxifen-inducible Cx43-icKD mice to reduce the expression of Cx43 and consequently the availability of hemichannels in EG ( Figure 1A and Supporting to avoid compensatory mechanisms due to complete Cx43 knockout and/or inhibition of gap junction coupling. It should be noted that homotypic Cx43 G138R connexons do not functionally couple, but can form gap junctions when wild-type Cx43 is expressed. Consequently, combination of these two models allows us to obtain EG with a dynamic range for Cx43 hemichannel activity/expression for a single allele, i.e., reduction or enhancement in Cx43-icKD or Cx43 G138R mice, respectively.
In vivo experiments were performed one week after tamoxifen administration. Body weight and total fecal pellet count were similar among the mice in all three groups: control, Cx43
G138R
, and Cx43-icKD (Supporting Information Figure S2A ,B). Furthermore, there was no significant difference in pellet weight and composition (Figure 2A motility, while an increase availability of hemichannels increases gut motility. As the latter manipulation is based on a Cx43 point mutation seen in ODDD, these are clinically relevant findings.
| Inhibition of Ca 21 -dependent exocytosis in EG affects fecal pellet composition
Regulated exocytosis is triggered by an increase in [Ca 21 ] i and requires the activity of a set of proteins, collectively known as SNAREs. These proteins are necessary for the fusion of secretory vesicles with the plasma membrane, which warrants release of the intravesicular content, i.e., transmitters and modulators, into the extracellular space. One of the SNAREs, synaptobrevin 2 (Sb2), is widely expressed in neurons and nonneuronal tissue (Rossetto et al., 1996) . This vesicular protein is necessary for Ca
21
-dependent exocytosis from astrocytes of the CNS (Jeftinija, Jeftinija, & Stefanovic, 1997) and hampering its operation, using the dominant negative SNARE (dnSNARE) approach, leads to the reduction of ATP release from astrocytes in situ (Pascual et al., 2005) . We tested whether EG utilize the exocytotic molecular machinery to regulate gut physiology.
Since activation of EG mainly leads to Ca 21 release from intracellular stores via IP 3 receptors (Gulbransen & Sharkey, 2009; Kimball & Mulholland, 1996) , we also tested if IP 3 signaling is involved in this process.
We used dnSNARE (Pascual et al., 2005) and VIPP (Marpegan et al., 2011; Foley et al., 2017) mice containing tet operon (tetO) driven cassettes that encode either the cytoplasmic domain of Sb2 (dnSNARE) and eGFP (expression marker) or the fusion protein between Venus fluorescent protein and IP 3 5-phosphatase (VIPP), respectively ( Figure   3A ). Transcription of each tetO driven cassette is controlled by tetracycline transactivator, expression of which is driven by the hGFAP promoter fragment. Consequently, after the removal of tetracycline analog doxycycline from animals diet, the cistron products in the gut are only expressed in the GFAP positive cells, i.e., EG of the ENS ( Figure 3B ), which leads to tampering directly with the exocytotic secretory machinery (dnSNARE mice) or with the upstream Ca 21 /IP 3 signaling (VIPP mice) (Supporting Information Figure S1B ). The experiments below were conducted on animals that were withdrawn from doxycycline containing food for 6-7 weeks.
Body weight, total fecal pellet count and intestine length were not significantly different between the mice in all three groups: control, dnSNARE and VIPP (Supporting Information Figure S3 ). Additionally, pellet weight ( Figure 4A ) and in vivo gut transit velocities did not significantly differ among the groups ( Figure 4C ). However, there was a significant increase in the fluid content of pellets originating from dnSNARE mice when compared with that of the control group ( Figure 4B) ; the VIPP group showed only a trend in an increase of median fluid content.
Overall, these results indicate that exocytotic gliotransmitter release from EG affects fluid secretion/reabsorption, while is not involved in regulation of gut motility in vivo. However, there could still be subtle effects on gut motility exerted solely via the ENS, otherwise masked in our in vivo approach. We next addressed this issue using an ex vivo approach.
3.3 | Gut contractions are modifiable by both forms of local gliotransmission in an ex vivo colon preparation Baseline colon width and that during CMMCs, along with relative amplitude and duration of CMMCs were unaffected in Cx43 G138R and Cx43-icKD colon samples when compared with their controls ( Figure   5B , B',C, respectively). However, colons from Cx43-icKD mice showed a decrease in CMMC dwell time, velocity and frequency when compared with colons isolated from control animals ( Figure 5C ', D, E, respectively). Additionally, CMMC dwell time in Cx43-icKD colons was significantly smaller than that recorded from Cx43 G138R colons ( Figure   5C '). These findings are in a good agreement with the in vivo gut transit assays ( Figure 2C ).
CMMCs were also affected by EG specific inhibition of exocytotic molecular machinery and IP 3 -dependent Ca 21 signaling ( Figure   6 ). When compared with control, colons from dnSNARE mice showed a significant reduction in baseline colon width and CMMC velocity ( Figure 6B ,D, respectively), while colons from VIPP mice had significantly decreased relative CMMC amplitude ( Figure 6B') and CMMC frequency ( Figure 6E ). All the other CMMC characteristics were similar (i.e., statistically insignificant) in colons isolated from dnSNARE, VIPP and control mice. Thus, gut motility ex vivo, which is solely driven by the ENS, is modulated by EG exocytosis and IP 3 -dependent Ca 21 signaling. In experiments in vivo, this effect seems to be masked due to extrinsic innervation of the gut and/or tampering with GFAP-positive cells residing out of the gut (see discussion). 
| DISCUSSION
This study provides evidence for the role of two modes of local gliotransmission in gut physiology in vivo and colonic contractions ex vivo.
We used genetically modified mice to assess the role of EG transmission. The cell specificity of molecular genetics was achieved using the fragment of GFAP promotor. This was combined with inducible gene expression/excision to guard against otherwise unwanted developmental effects. For instance, vesicular SNAREs are required for proper migration of neural crest cells, which differentiate into enteric neurons and glia (Vohra et al., 2006) , thus, tampering with SNAREs in early development would obscure the interpretation of data. Albeit we selectively targeted EG in the ENS, other GFAP expressing cells regardless of their locations would be affected in our mouse models. Thus, the observed in vivo effects could be in part due to modified gliotransmission from astrocytes. These glial cells play a role in in the operation of the gut; e.g., astrocytes in the hindbrain play a role in gastric vagal reflex circuits and gastric motility (Hermann, Viard, & Rogers, 2014 ).
Consequently, we implemented an ex vivo approach using isolated colons, which are devoid of any extrinsic input and solely operate under the control of local ENS circuits. This approach unmasked the role of glial exocytosis and Ca
21
/IP 3 signaling in gut contractions otherwise not seen in the in vivo approach.
This "masking concept" begs for some speculation on its possible mechanism; we briefly explore one possible hypothetical scenario. EG residing in proximity to enteric neurons receive direct nerve fiber inputs through synapse-like, synaptoid contacts (Gabella, 1972 As in the case of astrocytes (Araque et al., 1999; Zorec et al., 2012) , gliotransmisison could modulate synaptic transmission and plasticity.
However, in the absence of extrinsic input, modulatory effect by EG on the local circuity could differ, quantitatively and/or qualitatively (being even opposing), perhaps due to difference in spatio-temporal nature of heterocellular signaling. For instance, the local circuit may be susceptible to modulation by gliotransmisson that is time-dependent on the activity of the specific extrinsic input. Similarly, the external input may recruit a subset of EG release sites, the spatio-temporal organization of which may differ from that of sites recruited without this input and rather based on intrinsic ENS or spontaneous EG activity. Certainly, the effects that EG may have on gut reflexes in presence/absence of the extrinsic nerve input(s) represent a research area that needs future experimental work.
Pre-existing literature highly favors ATP as a gliotransmitter being released via Cx43 hemichannel (McClain et al., 2014) or exocytosis (Pascual et al., 2005) in animal models used and to carry out the effects we observed. ATP can be measured in isolated gastrointestinal tissue using enzyme-linked microelectrodes with excellent sensitivity (Patel, 2014; Patel, Rogers, Wieder, O'Hare, & Boutelle, 2011) ; however, spatial resolution allowing for resolving the cellular source (e.g., neuron vs. glia) of ATP using this approach has not been attained, yet. While imaging of ATP at the cellular level is possible in isolated tissue (e.g., retina) (Newman, 2004) , it will likely be technically challenging task in the gut in vivo and we have not directly measured it. By no means have we claimed that the reported effects were mediated by ATP.
Rather, a variety of gliotransmitters released by either, or both mechanisms (Malarkey & Parpura, 2009 ) could mediate them. For instance, glutamate can modulate GI motility (Filpa et al., 2016) . The identity of gliotransmitter(s) utilized in EG-mediated modulation of gut physiology remains to be studied.
Release through Cx43 hemichannels on astrocytes in the CNS likely occurs only in pathological conditions. Namely, Cx43 hemichannel activity in astrocytes appears at odds with their voltage sensitivity, opening as membrane potentials become positive (Trexler, Bennett, Bargiello, & Verselis, 1996) ; astrocytes normally do not depolarize to such extent unless under pathophysiological conditions such as stoke and ischemia. This raises an issue of whether the results we observed might reflect upon the importance of gap junctions growing the diffusion capacity of molecules throughout the EG syncytium as opposed to Cx43-mediated gliotransmission. While diffusion capacity could play a role, glial Cx43 hemichannels have been reported fully operational in the ENS and to play a role in gut physiology (McClain et al., 2014) .
Cx43 knock-down hemizygous approach we used here differs from our prior work using Cx43 knock-out homozygous animals Of note, the hGFAP::CreER T2 parental line was obtained from a different source. Nonetheless, the present data using the Cx43 knockdown approach is qualitatively similar to that previously obtained using the knock out approach, although the effects seem less robust. For example, the statistically significant reduction in gut motility when compared (Figure 2B) . However, such an effect on mucosal secretion/reabsorption is seen here in hemizygous dnSNARE animals ( Figure 4B ).
FIG URE 6
Enteric glial exocytosis and IP 3 -dependent calcium signaling have modulatory roles on CMMCs. A. Representative ST maps obtained from isolated colons originating from control, dnSNARE and VIPP mice. As in Figure 5 , changes of the colon gut width are pseudocolor coded. B-E. CMMC properties: (B) baseline colon width (blue) and that during CMMCs (red); (B') relative CMMC amplitude; (C) CMMC duration; (C') CMMC dwell time; (D) CMMC velocity; and (E) CMMC frequency. *, P <.05 versus control (KWA followed by NKMC). #, P <.05 versus control (F-test two-sample for variances with the Bonferroni correction for experiment-wide significance level). All groups had equal number of colons/animals (n 5 4) [Color figure can be viewed at wileyonlinelibrary.com]
Be that as it may, our data might be providing for a novel hypothesis that these two gliotransmission mechanisms are, in fact, linked: connexin43 (Cx43), the major constituent of hemi-channels in EG, and exocytotic release sites interact, so that perturbing one would affect the other; ex vivo, this is perhaps evident from the common effects on CMMC frequency and velocity ( Figure 5D ,E and Figure 6D ,E). Cx43 hemichannels are not only permeable to ATP being released but also to Ca 21 , which enters from the extracellular space into the cytosol of EG in situ (McClain et al., 2014) . This Cx43-mediated increase in cytosolic ) or reduce Cx43 hemichannel activity (Dobrowolski et al., 2008) . Our results indicate that variable bowel disturbances in ODDD patients (Loddenkemper, Grote, Evers, Oelerich, & Stogbauer, 2002) could stem, at least in part, from the direct modification of EG Cx43 hemichannel availability, activity, permeability and/or coupling.
EG can respond to ADP/ATP by P2Y1/4 receptor activation, which leads to IP 3 -signaling and Ca 21 release from the endoplasmic reticulum (McClain et al., 2014) . Thus, we investigated VIPP mice. 
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